BELLONE, Federica
 Distribuzione geografica
Continente #
EU - Europa 5.844
NA - Nord America 5.299
AS - Asia 3.129
SA - Sud America 944
Continente sconosciuto - Info sul continente non disponibili 349
AF - Africa 97
OC - Oceania 3
Totale 15.665
Nazione #
US - Stati Uniti d'America 5.161
RU - Federazione Russa 3.189
SG - Singapore 1.351
CN - Cina 844
BR - Brasile 776
IE - Irlanda 626
IT - Italia 576
SE - Svezia 540
HK - Hong Kong 351
DE - Germania 242
FR - Francia 202
VN - Vietnam 172
PL - Polonia 104
FI - Finlandia 97
IN - India 94
GB - Regno Unito 86
CA - Canada 57
BD - Bangladesh 54
AR - Argentina 42
EC - Ecuador 41
NL - Olanda 37
MX - Messico 35
TR - Turchia 35
AT - Austria 33
IQ - Iraq 31
BE - Belgio 27
ZA - Sudafrica 27
CO - Colombia 25
ES - Italia 24
ID - Indonesia 24
JP - Giappone 21
PK - Pakistan 20
UZ - Uzbekistan 20
CL - Cile 18
CI - Costa d'Avorio 14
MA - Marocco 14
VE - Venezuela 13
EG - Egitto 12
MY - Malesia 12
PY - Paraguay 12
KR - Corea 11
SA - Arabia Saudita 11
UA - Ucraina 11
JM - Giamaica 10
LT - Lituania 10
JO - Giordania 9
HN - Honduras 8
IL - Israele 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
GT - Guatemala 7
AZ - Azerbaigian 6
NG - Nigeria 6
NO - Norvegia 6
UY - Uruguay 6
BH - Bahrain 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
PE - Perù 5
TN - Tunisia 5
BO - Bolivia 4
DZ - Algeria 4
EE - Estonia 4
GE - Georgia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
OM - Oman 4
TH - Thailandia 4
AL - Albania 3
AU - Australia 3
KE - Kenya 3
LK - Sri Lanka 3
NP - Nepal 3
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
CM - Camerun 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
LB - Libano 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CD - Congo 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 15.308
Città #
Ashburn 897
Moscow 875
Singapore 706
Dublin 622
Dallas 507
Chandler 498
San Jose 341
Hong Kong 310
Nyköping 308
Beijing 241
Messina 185
Council Bluffs 148
The Dalles 141
Munich 124
New York 118
Los Angeles 107
Princeton 104
Warsaw 96
Dearborn 94
Lauterbourg 91
Medford 77
São Paulo 71
Ann Arbor 70
Jacksonville 62
Ho Chi Minh City 59
Catania 56
Des Moines 55
Boardman 52
Buffalo 49
Bremen 45
Santa Clara 42
Guangzhou 41
Turku 39
Shenyang 38
Cambridge 35
Helsinki 34
Redondo Beach 34
Atlanta 31
Orem 31
Jinan 29
Seattle 28
Wilmington 28
Brussels 27
Tianjin 26
Houston 25
Milan 25
Curitiba 24
Hanoi 24
Rome 24
Frankfurt am Main 23
Chicago 22
Nanjing 22
Belo Horizonte 21
Nuremberg 21
Pune 21
Montreal 20
Rio de Janeiro 20
Chennai 19
Düsseldorf 19
Strasbourg 19
Brooklyn 17
San Francisco 17
San Mateo 17
Tashkent 17
Amsterdam 16
Boston 16
Shanghai 16
Nanchang 15
Porto Alegre 15
Quito 15
Abidjan 14
Columbus 14
Hebei 14
Johannesburg 14
Mexico City 14
Tokyo 14
Vienna 14
Brasília 13
Guayaquil 13
Mumbai 13
Palermo 13
Poplar 13
Zhengzhou 13
Denver 12
Goiânia 12
Baghdad 11
Central 11
Falls Church 11
Fremont 11
Manchester 11
Ningbo 11
Stockholm 11
Woodbridge 11
Hangzhou 10
Jakarta 10
London 10
Sheung Shui 10
Taizhou 10
Toronto 10
Cairo 9
Totale 8.439
Nome #
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 301
Anxiety levels as risk factor for osteoporosis in postmenopausal women 279
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 257
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 244
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 230
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 228
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 224
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 222
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 218
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 217
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 215
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 209
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 209
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 204
Association between cognitive reserve dimensions and frailty among older adults: A structured narrative review 199
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 195
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 194
Multiple osteoporotic fractures complicating Wolfram syndrome 193
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 193
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 191
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 191
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 189
Hyponatremia as a leading sign of hypopituitarism 187
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 185
Clinical psychological evaluation in elderly men with prostatic hypertrophy in treatment with Dutasteride. 185
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 184
Alexithymia and inflammatory bowel disease: A systematic review 178
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 174
Association between anxiety levels and osteoporosis in postmenopausal women. 174
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 172
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 168
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 167
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 166
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 165
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 165
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 164
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 160
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 160
Postprandial Hypotension and Impaired Postprandial Sustained and Selective Attention in Older Inpatients: Is There a Link? 159
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 159
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 159
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 156
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 155
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 154
A single bone lesion in a man with prostate cancer: a case report of Paget’s disease of bone 150
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 149
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 148
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 146
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 145
Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach 143
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 142
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 142
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 141
VASCULAR CALCIFICATIONS ARE RELATED TO SCLEROSTIN AND DICKKOPF-1 IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 141
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 139
Going Beyond the Visible in Type 2 Diabetes Mellitus: Defense Mechanisms and Their Associations With Depression and Health-Related Quality of Life 139
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 138
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 134
Vitamin D status is associated with anxiety levels in postmenopausal women evaluated for osteoporosis 133
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 133
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 133
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 130
Health related quality of life and anxiety in patients with Type 2 Diabetes Mellitus 129
Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D 128
EFFETTO CODA DI ALENDRONATO SULLA DENSITÀ MINERALE OSSEA IN DONNE CON OSTEOPOROSI POSTMENOPAUSALE: POSSIBILE RUOLO DELLA VITAMINA D 126
Quality of life in postmenopausal women: Which role for vitamin D? 125
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 124
Pain and Frailty in Hospitalized Older Adults 123
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs? 122
PULSED ELECTROMAGNETIC FIELDS MODULATE SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 122
Bone quality is associated with body composition measurements in patients with type 2 diabetes. 120
Changes in Cognitive and Functional Status and in Quality of Life of Older Outpatients during the COVID-19 Pandemic 119
An unusual bilateral groin pain after COVID-19 infection in an 82-year-old man 118
Vitamin D, bone metabolism, and fracture risk in polycystic ovary syndrome 116
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 113
Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome 112
VITAMIN D PROMOTES BONE MINERAL DENSITY ACCRUAL AFTER DISCONTINUATION OF ALENDRONATE 112
The association between hypoparathyroidism and cognitive impairment: a systematic review 110
Fatigue, sarcopenia, and frailty in older adults with inflammatory bowel disease 106
Vitamin d boosts alendronate tail effect on bone mineral density in postmenopausal women with osteoporosis 104
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 101
IMPATTO DEI LIVELLI DI ANSIA SULLA DENSITÀ MINERALE OSSEA IN DONNE IN POSTMENOPAUSA IN TRATTAMENTO CON BIFOSFONATI ORALI: RISULTATI DI UNO STUDIO DI COORTE LONGITUDINALE 101
Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health 99
Unlocking the Predictive Power of Nutritional Scores in Septic Patients 98
Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease 95
IL PAZIENTE ANZIANO CON MALATTIA INFIAMMATORIA CRONICA INTESTINALE: OSSERVAZIONI IN UN GRUPPO DI PAZIENTI AMBULATORIALI 95
Effects of denosumab on insulin resistance in postmenopausal women with osteoporosis 94
Psychological factors may impact on postmenpausal women fracture risk 87
Is the Pentagon-Copying Task More than a Cognitive Feature? Associations with Handgrip Strength, Gait Speed, and Frailty in Older Adults 86
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Calcium Homeostasis: Where We Stand Now 85
Vitamin D as predictor of anxiety levels in postmenopausal women. 85
Magnesium disorders: Myth or facts? 83
POS1119 A SINGLE DOSE OF ZOLEDRONATE INDUCES MODIFICATIONS OF SERUM VEGF IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN 83
Rates of hypomagnesemia and hypermagnesemia in medical settings 82
Is the relationship between erythropoiesis and renal function one of the secrets of extreme longevity? 76
SUN-343 Prevalence and Incidence of Hypomagnesemia and Hypermagnesemia in Medical Settings 76
Sclerostin and vascular pathophysiology 76
IMPACT OF ANXIETY LEVELS ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN TREATED WITH ORAL BIPHOSPHONATES: RESULTS FROM A LONGITUDINAL COHORT STUDY 75
Nutraceuticals as Alternative Approach against Cadmium-Induced Kidney Damage: A Narrative Review 74
Executive functions predict fracture risk in postmenopausal women assessed for osteoporosis 73
Totale 14.877
Categoria #
all - tutte 50.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022760 0 42 21 27 17 13 106 38 76 127 53 240
2022/20231.822 138 197 92 143 135 156 21 93 743 20 61 23
2023/2024658 33 82 33 71 45 140 33 88 3 13 22 95
2024/20252.637 66 51 44 177 146 92 88 452 597 233 230 461
2025/20267.858 433 544 522 482 680 1.556 994 1.022 971 366 126 162
2026/2027793 201 592 0 0 0 0 0 0 0 0 0 0
Totale 15.665